Search Results for: Cohort

March 5, 2025March 5, 2025

Multicenter, retrospective cohort study of antimycobacterial treatment-related harms among patients with non-tuberculosis Mycobacterium infections in the United States.

Publication date: Mar 04, 2025 Non-tuberculosis mycobacteria (NTM) are extensively drug-resistant organisms that require long-term therapy. The study purpose was to quantify the incidence of and risk factors for antimycobacterial-associated ... Read more

March 2, 2025March 2, 2025

Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social-emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study.

Tuberculosis Literature

Publication date: Mar 01, 2025 As pre-exposure prophylaxis (PrEP) implementation continues to scale up among pregnant people, accruing safety data following prenatal PrEP exposure remains important. In this study, we ... Read more

March 1, 2025March 1, 2025

Prevalence of Culture-Confirmed Pulmonary Tuberculosis Requiring ICU Admission and the Trend in Prevalence Before and During the COVID-19 Pandemic in a Tertiary Academic Medical Center in Kuala Lumpur, Malaysia: A 7-Year Retrospective Cohort Study.

Tuberculosis Literature

Publication date: Feb 28, 2025 There are limited data on pulmonary tuberculosis (PTB) requiring intensive care unit (ICU) admission despite its high mortality rate. The objectives of our study were ... Read more

February 28, 2025February 28, 2025

Clinical characteristics of acquired anti-IFN-γ autoantibodies in patients infected with non-tuberculous mycobacteria: a prospective cohort study.

Tuberculosis Literature

Publication date: Feb 27, 2025 Patients with positive anti-IFN-γ autoantibodies (AIGAs) are characterized by susceptibility to disseminated infection by multiple pathogens. The clinical characteristics of non-tuberculous mycobacterial (NTM) infection with ... Read more

February 26, 2025February 26, 2025

Clinical manifestations in patients with anti-IFN-γ autoantibodies syndrome and Talaromyces marneffei infection: a prospective cohort study.

Tuberculosis Literature

Publication date: Feb 25, 2025 Anti-interferon-γ autoantibodies syndrome (AIGAs syndrome) is characterized by disseminated infections involving various pathogens. The clinical manifestations of AIGAs syndrome with Talaromyces marneffei (TM) infection are ... Read more

February 22, 2025February 22, 2025

Factors influencing treatment success in drug-susceptible tuberculosis patients in Ghana: A prospective cohort study.

Tuberculosis Literature

Publication date: Dec 05, 2024 Optimal rates of positive tuberculosis (TB) treatment outcomes are crucial for patient well-being and preventing the emergence of drug-resistant strains. Unfavourable outcomes present significant challenges ... Read more

February 22, 2025February 22, 2025

The prevalence and pattern of post tuberculosis lung disease including pulmonary hypertension from an Australian TB service; a single-centre, retrospective cohort study.

Tuberculosis Literature

Publication date: Feb 21, 2025 Post Tuberculosis Lung Disease (PTLD) is increasingly recognised as a significant cause of morbidity internationally, but has not been described in an Australian setting. We ... Read more

February 21, 2025February 21, 2025

Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.

Tuberculosis Literature

Publication date: Feb 20, 2025 Adverse drug reactions (ADRs) to tuberculosis (TB) medications make treatment completion challenging. We investigated the impact of alcohol, human immunodeficiency virus (HIV), and other patient ... Read more

February 21, 2025February 21, 2025

Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study.

Tuberculosis Literature

Publication date: Feb 20, 2025 Tuberculosis remains the leading cause of death among people with HIV. The aim of this study was to describe the incidence of tuberculosis (TB), explore ... Read more

February 19, 2025February 19, 2025

The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.

Tuberculosis Literature

Publication date: Feb 18, 2025 Only 63% of patients initiating multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment in 2020 were treated successfully. 24-Week all-oral bedaquiline, pretomanid, and linezolid (BPaL)-based regimens have demonstrated higher ... Read more